Abstract
The mechanism of antimalarial action of the ruthenium–chloroquine complex [RuCl2(CQ)]2 (1), previously shown by us to be active in vitro against CQ-resistant strains of Plasmodium falciparum and in vivo against P. berghei, has been investigated. The complex is rapidly hydrolyzed in aqueous solution to [RuCl(OH2)3(CQ)]2[Cl]2, which is probably the active species. This compound binds to hematin in solution and inhibits aggregation to β-hematin at pH ∼ 5 to a slightly lower extent than chloroquine diphosphate; more importantly, the heme aggregation inhibition activity of complex 1 is significantly higher than that of CQ when measured at the interface of n-octanol–aqueous acetate buffer mixtures under acidic conditions modeling the food vacuole of the parasite. Partition coefficient measurements confirmed that complex 1 is considerably more lipophilic than CQ in n-octanol–water mixtures at pH ∼ 5. This suggests that the principal target of complex 1 is the heme aggregation process, which has recently been reported to be fast and spontaneous at or near water–lipid interfaces. The enhanced antimalarial activity of complex 1 is thus probably due to a higher effective concentration of the drug at or near the interface compared with that of CQ, which accumulates strongly in the aqueous regions of the vacuole under those conditions. Furthermore, the activity of complex 1 against CQ-resistant strains of P. falciparum is probably related to its greater lipophilicity, in line with previous reports indicating a lowered ability of the mutated transmembrane transporter PfCRT to promote the efflux of highly lipophilic drugs. The metal complex also interacts with DNA by intercalation, to a comparable extent and in a similar manner to uncomplexed CQ and therefore DNA binding does not appear to be an important part of the mechanism of antimalarial action in this case.
Similar content being viewed by others
References
http://www.who.int/mediacentre/factsheets/fs094/en/index.html (WHO Fact Sheets)
Sachs J, Malaney P (2002) Nature 415:680–685
Winstanley PA (2000) Parasitol Today 16:146–153
Rosenthal PhJ (ed) (2001) Antimalarial chemotherapy: mechanisms of action, resistance and new directions in drug discovery. Humana Press, New Jersey
Weisner J, Ortmann R, Jomaa H, Schlitzer M (2003) Angew Chem Int Ed 42:5274–5293
Kumar S, Guha M, Choubey V, Maity P, Bandyopadhyay U (2007) Life Sci 80:813–828
Wellems TE (2002) Science 298:124–127
Egan TJ, Marques HM (1999) Coord Chem Rev 190-192:493–517
Ziegler J, Linck R, Wrigth DW (2001) Curr Med Chem 8:171–189
Tilley L, Loria P, Foley M (2001) In: Rosenthal PhJ (ed) Antimalarial chemotherapy: mechanisms of action, resistance and new directions in drug discovery. Humana Press, New Jersey, pp 87–121
Pagola S, Stephens PW, Bohle DS, Kosar AD, Madsen SK (2000) Nature 378:138–139
Cohen SN, Yielding KL (1965) Proc Nat Acad Sci 54:521–527
Guetzoyan L, Ramiandrasoa F, Dorizon H, Desprez C, Bridoux A, Rogier C, Pradines B, Perrée-Fauvet M (2007) Bioorg Med Chem 15:3278–3289
Dheyongera JP, Geldenhuys WJ, Dekker TG, Matsabisa MG, Van der Schyf CJ (2005) Bioorg Med Chem 13:1653–1659
Van Miert S, Jonckers T, Cimanga K, Maes L, Maes B, Lemière G, Dommisse R, Vlietinck A, Pieters L (2004) Exp Parasitol 108:163–168
Dorsey G, Fidock DA, Wellems TE, Rosenthal, PhJ (2001) In: Rosenthal PhJ (ed) (2001) Antimalarial chemotherapy: mechanisms of action, resistance and new directions in drug discovery. Humana Press, New Jersey, pp 153–172
Sanchez C, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M (2005) Biochem 44:9862–9870
Sanchez C, McLean JE, Stein WD, Lanzer M (2004) Biochem 43:16365–16373
van Schalkwyk DA, Egan TJ (2006) Drug Resist Updat 9:211–226
Siegel H, Siegel A (eds) (2004) Metal ions and their complexes in medication. Metal ions in biological systems, vol 41. Marcel Dekker, New York
Sánchez-Delgado RA, Anzellotti A (2004) Mini Rev Med Chem 4:23–30
Sánchez-Delgado RA, Anzellotti A, Suárez L (2004) In: Siegel H, Siegel A (eds) Metal ions and their complexes in medication. Metal ions in biological systems, vol 41. Marcel Dekker, New York, pp 379–419
Sánchez-Delgado RA, Lazardi K, Rincón L, Urbina JA, Hubert AJ, Noels AN (1993) J Med Chem 36:2041–2043
Sánchez-Delgado RA, Navarro M, Lazardi K, Atencio R, Capparelli M, Vargas F, Urbina JA, Bouillez A, Noels AF, Masi D (1998) Inorg Chim Acta 275-276:528–540
Navarro M, Lehmann T, Cisneros EJ, Fuentes A, Sánchez-Delgado RA, Silva P, Urbina JA (2000) Polyhedron 19:2319–2325
Navarro M, Cisneros-Fajardo E, Lehmann T, Sánchez-Delgado RA, Atencio R, Silva P, Lira R, Urbina JA (2001) Inorg Chem 40:6879–6884
Strasberg-Rieber M, Anzellotti A, Sánchez-Delgado RA, Rieber M (2004) Int J Cancer 112:376–384
Sánchez-Delgado RA, Navarro M, Pérez H, Urbina JA (1996) J Med Chem 39:1095–1099
Navarro M, Pérez H, Sánchez-Delgado RA (1997) J Med Chem 40:1937–1939
Navarro M, Vásquez F, Sánchez-Delgado RA, Pérez H, Sinou V, Schrevel J (2004) J Med Chem 47:5204–5209
Biot C (2004) Curr Med Chem Anti-Infect Agents 3:135–147
Biot C, Daher W, Ndiaye CM, Melnyk P, Pradines B, Chavain N, Pellet A, Fraisse L, Pelinski L, Jarry C, Brocard J, Khalife J, Forfar-Bares I, Dive D (2006) J Med Chem 49:4707–4714
Egan TJ, Mavuso WW, Ross D, Marques HM (1997) J Inorg Biochem 68:137–145
Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ (2005) Mol Pharm 2:185–193
Parapini S, Basilico N, Pasini E, Egan TJ, Olliaro P, Taramelli D, Monti D (2000) Exp Parasitol 96:249–256
Egan TJ, Chen JY-J, de Villiers KA, Mabotha TE, Naidoo KJ, Ncokazi KK, Langford SJ, McNaughton D, Pandiancherri S, Word BR (2006) FEBS Lett 580:5105–5110
OECD Guidelines for testing of chemicals (1995) No. 107, OECD, Paris
Danielsson LG, Zhang YH (1996) Trends Anal Chem 15:188–196
Rappel C, Galanski M, Yasemi A, Habala L, Keppler B (2005) Electrophoresis 26:878–884
Wolf A, Shimer Jr GH, Meehan T (1987) Biochemistry 26:6392–6396
Navarro M, Hernández C, Colmenares I, Hernández P, Fernández M, Sierralta A, Marchán E (2007) J Inorg Biochem 101:111–116
McGhee JD, Von Hippel PH (1974) J Mol Biol 86:469–489
Wei C, Jia G, Yuan J, Feng Z, Li C (2006) Biochemistry 45:6681–6691
Boyer R (2006) Biochemistry laboratory: modern theory and techniques. Benjamin Cummings, Reading, pp 253–260
Cusumano M, Di Pietro ML, Giannetto A, (1999) Inorg Chem 38:1754–1758
Satyanarayana S, Dabrowiak JC, Chaires J (1992) Biochem 31:9319–9324
Corrêa Soares JBR, Maya-Monteiro CM, Bittencourt-Cunha PRB, Atella GC, Lara FA, d’Avila JCP, Menezes D, Vannier-Santos MA, Oliveira PL, Egan TJ, Oliveira MF (2007) FEBS Lett 581:1742–1750, and references therein
Jackson KE, Klonis N, Ferguson DJ, Adisa A, Dogovski C, Tilley L (2004) Mol Microbiol 54:109–122
Benjamin I (2004) Chem Phys Lett 393:453–456
Warhurst DC (2003) Malaria J 2:31–43
Warhurst DC, Craig JC, Adagu IS, Meyer DJ, Lee SY (2003) Malaria J 2:26–30
Meshnick SR (1990) Parasitol Today 6:77–79
Li G-D (2006) Med Hypotheses 67:323–326
Wang Y, Yang ZY (2005) Trans Med Chem 30:902–906
Satyanarayana S, Dabrowiak JC, Chaires J (1992) Biochem 31:9319–9324
Novakova O, Chen H, Vrana O, Rodger A, Sadler PJ, Bravec V (2003) Biochem 42:11544–11554
Farrell N (1989) Transition metal complexes as drugs and chemotherapeutic agents. Kluwer, Dordrecht
Acknowledgments
Financial support from the NIH through grants no. 1S06 GM 076168-04 (to R.A.S.-D) and 1S06 GM 076168-01 (to L.D.) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Martínez, A., Rajapakse, C.S.K., Naoulou, B. et al. The mechanism of antimalarial action of the ruthenium(II)–chloroquine complex [RuCl2(CQ)]2 . J Biol Inorg Chem 13, 703–712 (2008). https://doi.org/10.1007/s00775-008-0356-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-008-0356-9